AMCP Opposes Med Part D Changes, Citing Letters to Administration

For Immediate Release
 

Alexandria, Va., February 21, 2014 — Edith A. Rosato, RPh, IOM, CEO of the Academy of Managed Care Pharmacy (AMCP), today commended three congressional leaders – House Ways and Means Chairman Dave Camp (R-MI), Energy and Commerce Chairman Fred Upton (R-MI) and Senate Finance Committee Ranking Member Orrin Hatch (R-UT) – for their letter calling on the administration to withdraw its proposed changes to the Medicare Part D program for 2015.
 
That letter follows one signed by over 230 stakeholder organizations, including AMCP, also calling on the administration to withdraw the proposed rule.
 
AMCP CEO Rosato issued the following statement:
 
"In considering CMS' Medicare Part D proposal, two old adages come to mind: "If it ain't broke, don't fix it" and "First, do no harm." 
 
"Regarding the former, Medicare Part D is an undeniable success, working as well or better than any other federal health care program in existence. As the stakeholder letter signed by AMCP states, "The Part D program has maintained stable, affordable average monthly premiums, enjoys a 90 percent approval rating among beneficiaries, and has program costs that are more than 40 percent below original Congressional Budget Office projections." 
 
"It doesn't get much better than that." 
 
"More worrisome is the harm the changes would do. The shackles it would place on health plans could very well reduce access to and affordability of health care. In fact, all but one of the changes would roll back CMS' recent progress in reducing program costs and increasing access to affordable medications. These provisions would end successful preferred networks, limit access to cost-saving mail order pharmacy, and expand Part D's medication therapy management program despite the government's own analysis that finds limited impact on patient outcomes and limited reductions in hospitalizations." 
 
"The only silver lining is the draft rule scales back requirements for medications in three of the six protected classes. We commend CMS for recognizing the positive role that pharmacy and therapeutics committees play in selecting safe and effective medications for formularies. But CMS should scale back the number of protected classes further." 
 
About AMCP  
The Academy of Managed Care Pharmacy is a national professional association of pharmacists and other health care practitioners who serve society by the application of sound medication management principles and strategies to improve health care for all. The Academy's nearly 7,000 members develop and provide a diversified range of clinical, educational and business management services and strategies on behalf of the more than 200 million Americans covered by a managed care pharmacy benefit. It is celebrating its 25th anniversary in 2013. More news and information about the Academy can be found at www.amcp.org
 
 
For more information, please contact:
Kevin Bruns | kbruns@amcp.org 703-683-8416 ext. 656